Literature DB >> 6148381

EMG patterns in abnormal involuntary movements induced by neuroleptics.

N Bathien, R M Koutlidis, P Rondot.   

Abstract

Electromyographic (EMG) activity of abnormal involuntary movements and their modifications after Piribedil, a dopaminergic agonist, were analysed in patients presenting with tremor or tardive dyskinesia induced by treatment with neuroleptics. Quantitative analysis of EMG bursts and of their phase relationships with bursts of antagonist muscles revealed differences between tremor and tardive dyskinesia; three separate EMG types of the latter were found. In tremor, EMG activity was coordinated between agonists and antagonists. Length and frequency of bursts are characteristic. In tardive dyskinesia, phase histograms of antagonist muscle bursts showed an absence of reciprocal organisation of EMG activity. This activity was made up of either rhythmical bursts (type I and II according to the frequency) or irregular discharges (type III). Piribedil decreased tremor but facilitated EMG activity in tardive dyskinesia. These results give an objective measurement or classification of tremor and tardive dyskinesia induced by neuroleptics.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148381      PMCID: PMC1028005          DOI: 10.1136/jnnp.47.9.1002

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  [4 Cases of facio-bucco-linguo-masticatory dyskinesis of prolonged development following treatment with neuroleptics].

Authors:  J SIGWALD; D BOUTTIER; C RAYMONDEAUD; C PIOT
Journal:  Rev Neurol (Paris)       Date:  1959-06       Impact factor: 2.607

Review 2.  Persistent dyskinesia.

Authors:  G E Crane
Journal:  Br J Psychiatry       Date:  1973-04       Impact factor: 9.319

3.  Organization of pallidothalamic projections in the rhesus monkey.

Authors:  J S Kuo; M B Carpenter
Journal:  J Comp Neurol       Date:  1973-10-01       Impact factor: 3.215

4.  [Dopamine and abnormal movements].

Authors:  P Rondot; R J Dumas
Journal:  Rev Neurol (Paris)       Date:  1972-07       Impact factor: 2.607

5.  Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.

Authors:  A Clow; A Theodorou; P Jenner; C D Marsden
Journal:  Adv Biochem Psychopharmacol       Date:  1980

Review 6.  Tardive dyskinesia: pharmacology and clinical implications.

Authors:  C G Goetz; W J Weiner; P A Nausieda; H L Klawans
Journal:  Clin Neuropharmacol       Date:  1982       Impact factor: 1.592

7.  The monkey globus pallidus: neuronal discharge properties in relation to movement.

Authors:  R Iansek; R Porter
Journal:  J Physiol       Date:  1980-04       Impact factor: 5.182

8.  Changes in dopamine-mediated behaviour during one year's neuroleptic administration.

Authors:  A Clow; P Jenner; C D Marsden
Journal:  Eur J Pharmacol       Date:  1979-08-15       Impact factor: 4.432

9.  [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].

Authors:  N Bathien; P Rondot; R M Koutlidis
Journal:  J Physiol (Paris)       Date:  1981-04

10.  [Abnormal movements induced by psychotropic drugs].

Authors:  P Rondot; N Bathien
Journal:  Encephale       Date:  1979       Impact factor: 1.291

View more
  3 in total

1.  Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 2.  Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson's disease motor symptoms.

Authors:  Anirudha S Chandrabhatla; I Jonathan Pomeraniec; Alexander Ksendzovsky
Journal:  NPJ Digit Med       Date:  2022-03-18

3.  Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns.

Authors:  Sven Janno; Matti M Holi; Katinka Tuisku; Kristian Wahlbeck
Journal:  BMC Neurol       Date:  2008-04-18       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.